Z-0779-2017 Class III Terminated
FDA device recall Z-0779-2017 was initiated by PerkinElmer Health Sciences, Inc. on Nov 16, 2016 and is designated Class III. Reason for recall: A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was… The recall status is terminated (terminated Jul 5, 2017). Affected quantity: 79 kits.
Recall details
- Product Type
- Devices
- Report Date
- Dec 28, 2016
- Initiation Date
- Nov 16, 2016
- Termination Date
- Jul 5, 2017
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 79 kits
Product description
DELFIA hFSH kit. In Vitro Diagnostic for the determination of hFSH in serum
Reason for recall
A DELFIA hFSH kit lot failed real time stability testing. The real time stability data demonstrated a decrease in hFSH concentrations between -4.8% to -11.3% for control sera. The -11.3% bias was observed at an hFSH target concentration of 101 IU/L. The change observed in the serum samples within the range 1.76 67.0 IU/L hFSH averaged -2.9%. The reference range of the assay spans 0.60 to 98.0 IU/L.
Distribution pattern
CA, CO, NY, WA Foreign: Austria, Bolivia, Bosnia , Sweden, Norway, Netherlands, Japan, Great Britain,
Code information
Lot Number: 646091
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0779-2017
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026